By Professor John Philip Chalmers

Journal articles

Czernichow S; Van Dieren S; Pascal Kengne A; Chalmers J; Marre M; Zoungas S, 2011, 'P283 - Déterminants de la variation du poids dans l’étude ADVANCE', Diabetes & Metabolism, 37, pp. A100 - A100, http://dx.doi.org/10.1016/s1262-3636(11)70909-0

Chalmers J; Woodward M; Rodgers A; Chow C; Patel A; Webster R; Batty D; Li Q; Ninomiya T; Zoungas S; Hillis G, 2011, 'RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS', Journal of Hypertension, 29, pp. e113 - e114, http://dx.doi.org/10.1097/00004872-201106001-00280

Lambers Heerspink HJ; Ninomiya T; Perkovic V; Woodward M; Zoungas S; Cass A; Cooper M; Grobbee DE; Mancia G; Mogensen CE; Neal B; Chalmers J, 2010, 'Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease', European Heart Journal, 31, pp. 2888 - 2896, http://dx.doi.org/10.1093/eurheartj/ehq139

Batty GD; Li Q; Czernichow S; Neal B; Zoungas S; Huxley R; Patel A; De Galan BE; Woodward M; Hamet P; Harrap SB; Poulter N; Chalmers J, 2010, 'Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: Prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial', Journal of the American College of Cardiology, 56, pp. 1908 - 1913, http://dx.doi.org/10.1016/j.jacc.2010.04.067

Arima H; Anderson CS; Wang JG; Huang Y; Heeley E; Neal B; Woodward M; Skulina C; Parsons MW; Peng B; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Morgenstern LB; Chalmers J, 2010, 'Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage', Hypertension, 56, pp. 852 - 858, http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.154328

Li Q; Chalmers J; Czernichow S; Neal B; Taylor BA; Zoungas S; Poulter N; Woodward M; Patel A; De Galan B; Batty GD, 2010, 'Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: A prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial', Diabetologia, 53, pp. 2320 - 2327, http://dx.doi.org/10.1007/s00125-010-1862-1

Zoungas S; Patel A; Chalmers J; De Galan BE; Li Q; Billot L; Woodward M; Ninomiya T; Neal B; MacMahon S; Grobbee DE; Kengne AP; Marre M; Heller S, 2010, 'Severe hypoglycemia and risks of vascular events and death', New England Journal of Medicine, 363, pp. 1410 - 1418, http://dx.doi.org/10.1056/NEJMoa1003795

Lee CC; Stolk RP; Adler AI; Patel A; Chalmers J; Neal B; Poulter N; Harrap S; Woodward M; Marre M; Grobbee DE; Beulens JW, 2010, 'Association between alcohol consumption and diabetic retinopathy and visual acuity - The AdRem Study', Diabetic Medicine, 27, pp. 1130 - 1137, http://dx.doi.org/10.1111/j.1464-5491.2010.03080.x

Glasziou PP; Clarke P; Alexander J; Rajmokan M; Beller E; Woodward M; Chalmers J; Poulter N; Patel A, 2010, 'Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: An ADVANCE trial-based analysis', Medical Journal of Australia, 193, pp. 320 - 324, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03941.x

Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A, 2010, 'Aspirin is beneficial in hypertensive patients with chronic kidney disease: A post-hoc subgroup analysis of a randomized controlled trial', Journal of the American College of Cardiology, 56, pp. 956 - 965, http://dx.doi.org/10.1016/j.jacc.2010.02.068

Brugts JJ; Isaacs A; Boersma E; Van Duijn CM; Uitterlinden AG; Remme W; Bertrand M; Ninomiya T; Ceconi C; Chalmers J; MacMahon S; Fox K; Ferrari R; Witteman JCM; Danser AHJ; Simoons ML; De Maat MPM, 2010, 'Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease', European Heart Journal, 31, pp. 1854 - 1864, http://dx.doi.org/10.1093/eurheartj/ehq169

Zoungas S; Chalmers J; Kengne AP; Pillai A; Billot L; de Galan B; Marre M; Neal B; Harrap S; Poulter N; Patel A, 2010, 'The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial', Diabetes Research and Clinical Practice, 89, pp. 126 - 133, http://dx.doi.org/10.1016/j.diabres.2010.05.012

Heeley EL; Anderson CS; Patel AA; Cass A; Peiris DP; Chalmers JP, 2010, 'Cardiovascular risk perception and evidence-practice gaps in Australian general practice REPLY', MEDICAL JOURNAL OF AUSTRALIA, 193, pp. 127 - 128, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03824.x

Heeley EL; Anderson CS; Patel AA; Cass A; Peiris DP; Chalmers JP, 2010, 'In reply', Medical Journal of Australia, 193, pp. 127 - 128, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03824.x

Kengne AP; Czernichow S; Chalmers J, 2010, 'Blood pressure variables and cardiovascular risk in type 2 diabetes in the ADVANCE trial', Sang Thrombose Vaisseaux, 22, pp. 264 - 270, http://dx.doi.org/10.1684/stv.2010.0476

Czernichow S; Ninomiya T; Huxley R; Kengne AP; Batty GD; Grobbee DE; Woodward M; Neal B; Chalmers J, 2010, 'Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: The perindopril protection against recurrent stroke study trial', Hypertension, 55, pp. 1193 - 1198, http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.140624

Kengne AP; Patel A; Colagiuri S; Heller S; Hamet P; Marre M; Pan CY; Zoungas S; Grobbee DE; Neal B; Chalmers J; Woodward M, 2010, 'The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: The Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study', Diabetologia, 53, pp. 821 - 831, http://dx.doi.org/10.1007/s00125-010-1681-4

Head GA; Mihailidou AS; Duggan KA; Beilin LJ; Berry N; Brown MA; Bune AJ; Cowley D; Chalmers JP; Howe PRC; Hodgson J; Ludbrook J; Mangoni AA; McGrath BP; Nelson MR; Sharman JE; Stowasser M, 2010, 'Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: Prospective cohort study', BMJ (Online), 340, pp. 849, http://dx.doi.org/10.1136/bmj.c1104

Delcourt C; Huang Y; Wang J; Heeley E; Lindley R; Stapf C; Tzourio C; Arima H; Parsons M; Sun J; Neal B; Chalmers J; Anderson C, 2010, 'The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2)', International Journal of Stroke, 5, pp. 110 - 116, http://dx.doi.org/10.1111/j.1747-4949.2010.00415.x

Heeley EL; Peiris DP; Patel AA; Cass A; Weekes A; Morgan C; Anderson CS; Chalmers JP, 2010, 'Cardiovascular risk perception and evidence-practice gaps in Australian general practice (the AusHEART study)', Medical Journal of Australia, 192, pp. 254 - 259, http://dx.doi.org/10.5694/j.1326-5377.2010.tb03502.x

Patel A; Neal B; Chalmers J, 2010, 'Event rates in trials of patients with type 2 diabetes [5]', JAMA, 303, pp. 732, http://dx.doi.org/10.1001/jama.2010.137

Anderson CS; Huang Y; Arima H; Heeley E; Skulina C; Parsons MW; Peng B; Li Q; Su S; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Morgenstern LB; Chalmers J; Wang JG, 2010, 'Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: The intensive blood pressure reduction in acute cérébral haemorrhage trial (INTERACT)', Stroke, 41, pp. 307 - 312, http://dx.doi.org/10.1161/STROKEAHA.109.561795

Arima H; Tzourio C; Anderson C; Woodward M; Bousser MG; MacMahon S; Neal B; Chalmers J, 2010, 'Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: The progress trial', Stroke, 41, pp. 394 - 396, http://dx.doi.org/10.1161/STROKEAHA.109.563932

Clarke PM; Glasziou P; Patel A; Chalmers J; Woodward M; Harrap SB; Salomon JA, 2010, 'Event rates, hospital utilization, and costs associated with major complications of diabetes: A multicountry comparative analysis', PLoS Medicine, 7, http://dx.doi.org/10.1371/journal.pmed.1000236

Jun M; Foote C; Lv J; Neal B; Patel A; Nicholls SJ; Grobbee DE; Cass A; Chalmers J; Perkovic V, 2010, 'Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis', The Lancet, 375, pp. 1875 - 1884, http://dx.doi.org/10.1016/S0140-6736(10)60656-3

Ninomiya T; Zoungas S; Neal B; Woodward M; Patel A; Perkovic V; Cass A; Cooper M; Grobbee D; Hamet P; Harrap S; Liu L; Mancia G; Mogensen CE; Poulter N; Rodgers A; Williams B; MacMahon S; Chalmers J, 2010, 'Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial', Journal of Hypertension, 28, pp. 1141 - 1149, http://dx.doi.org/10.1097/HJH.0b013e328338a89c

Chalmers J; Harrap S; Narkiewicz K; Poulter N; Redon J; Zanchetti A; Mancia G, 2010, 'Issues in the development of new combinations of blood pressure lowering drugs', Journal of Hypertension, 28, pp. 2494 - 2496, http://dx.doi.org/10.1097/HJH.0b013e328340d702

Arima H; Anderson C; Omae T; Liu L; Tzourio C; Woodward M; MacMahon S; Neal B; Rodgers A; Chalmers J, 2010, 'Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: The PROGRESS trial', Journal of Hypertension, 28, pp. 395 - 400, http://dx.doi.org/10.1097/HJH.0b013e328333b009

Ruilope LM; Mancia G; Chalmers J, 2010, 'DOES USE OF ANTIHYPERTENSIVE TREATMENT TO REDUCE ALBUMINURIA TRANSLATE INTO EFFECTIVE BENEFITS ON OUTCOME AND MORTALITY? A REAPPRAISAL OF STUDIES WITH RENAL ENDPOINTS IN DIABETES: PP.16.105', Journal of Hypertension, 28, pp. e281 - e281, http://dx.doi.org/10.1097/01.hjh.0000379031.35224.c0

Czernichow S; Lee C; Barzi F; Greenfield JR; Baur LA; Chalmers J; Woodward M; Huxley R, 2010, 'Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials', Obesity Reviews, 11, pp. 150 - 158

Clarke PM; Glasziou P; Alexander J; Chalmers J; Patel A, 2010, 'HT3 COST-EFFECTIVENESS OF BLOOD PRESSURE LOWERING WITH A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN TYPE 2 DIABETES MELLITUS: A TRIAL-BASED ANALYSIS USING THE ADVANCE STUDY', Value in Health, 13, pp. A504 - A504, http://dx.doi.org/10.1016/s1098-3015(11)73064-9

Chalmers J; Zoungas S; Ninomiya T, 2010, 'OPTIMAL HYPERTENSION MANAGEMENT WITH PRETERAX: S3.1', Journal of Hypertension, 28, pp. e609 - e609, http://dx.doi.org/10.1097/01.hjh.0000383854.11373.9d

De Galan BE; Zoungas S; Chalmers J; Anderson C; Dufouil C; Pillai A; Cooper M; Grobbee DE; Hackett M; Hamet P; Heller SR; Lisheng L; MacMahon S; Mancia G; Neal B; Pan CY; Patel A; Poulter N; Travert F; Woodward M, 2009, 'Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: The action in diabetes and vascular disease: Preterax and diamicron modified release controlled evaluation (ADVANCE) trial', Diabetologia, 52, pp. 2328 - 2336, http://dx.doi.org/10.1007/s00125-009-1484-7

Zoungas S; De Galan BE; Ninomiya T; Grobbee D; Hamet P; Heller S; MacMahon S; Marre M; Neal B; Patel A; Woodward M; Chalmers J; Perkovic V, 2009, 'Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial', Diabetes Care, 32, pp. 2068 - 2074, http://dx.doi.org/10.2337/dc09-0959

Turnbull FM; Abraira C; Anderson RJ; Byington RP; Chalmers JP; Duckworth WC; Evans GW; Gerstein HC; Holman RR; Moritz TE; Neal BC; Ninomiya T; Patel AA; Paul SK; Travert F; Woodward M, 2009, 'Intensive glucose control and macrovascular outcomes in type 2 diabetes', Diabetologia, 52, pp. 2288 - 2298, http://dx.doi.org/10.1007/s00125-009-1470-0

Neal B; Ninomiya T; Donnan G; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Chalmers J; Woodward M, 2009, 'Response to letter by Kerr and Nasco', Stroke, 40, http://dx.doi.org/10.1161/STROKEAHA.109.563676

Zoungas S; Chalmers J; Patel A, 2009, 'Cardiovascular Risk in Type 2 Diabetes—Reflecting on the ADVANCE Study', US Cardiology Review, 6, pp. 46 - 50, http://dx.doi.org/10.15420/usc.2009.6.2.46

Joshi R; de Galan BE; Chalmers J; Perkovic V; Patel A, 2009, 'Routine blood pressure lowering and intensive glucose control in patiens with type 2 diabetes: The ADVANCE trial', Expert Review of Endocrinology and Metabolism, 4, pp. 111 - 118, http://dx.doi.org/10.1586/17446651.4.2.111

Kengne AP; Czernichow S; Huxley R; Grobbee D; Woodward M; Neal B; Zoungas S; Cooper M; Glasziou P; Hamet P; Harrap SB; Mancia G; Poulter N; Williams B; Chalmers J, 2009, 'Blood pressure variables and cardiovascular risk: New findings from advance', Hypertension, 54, pp. 399 - 404, http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.133041

Ninomiya T; Donnan G; Anderson N; Bladin C; Chambers B; Gordon G; Sharpe N; Chalmers J; Woodward M; Neal B, 2009, 'Effects of the end point adjudication process on the results of the perindopril protection against recurrent stroke study (PROGRESS)', Stroke, 40, pp. 2111 - 2115, http://dx.doi.org/10.1161/STROKEAHA.108.539601

Dufouil C; Godin O; Chalmers J; Coskun O; Macmahon S; Tzourio-Mazoyer N; Bousser MG; Anderson C; Mazoyer B; Tzourio C, 2009, 'Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history', Stroke, 40, pp. 2219 - 2221, http://dx.doi.org/10.1161/STROKEAHA.108.540633

Brugts JJ; Ninomiya T; Boersma E; Remme WJ; Bertrand M; Ferrari R; Fox K; MacMahon S; Chalmers J; Simoons ML, 2009, 'The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: A combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials', European Heart Journal, 30, pp. 1385 - 1394, http://dx.doi.org/10.1093/eurheartj/ehp103

Du X; Ninomiya T; De Galan B; Abadir E; Chalmers J; Pillai A; Woodward M; Cooper M; Harrap S; Hamet P; Poulter N; Lip GYH; Patel A, 2009, 'Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: Results of the ADVANCE study', European Heart Journal, 30, pp. 1128 - 1135, http://dx.doi.org/10.1093/eurheartj/ehp055

Harrap S; Patel A; Chalmers J, 2009, 'New perspectives in the treatment of the diabetic patient. ADVANCE Study', Hipertension y Riesgo Vascular, 26, pp. 80 - 83, http://dx.doi.org/10.1016/S1889-1837(09)71180-8

Ninomiya T; Perkovic V; Verdon C; Barzi F; Cass A; Gallagher M; Jardine M; Anderson C; Chalmers J; Craig JC; Huxley R, 2009, 'Proteinuria and Stroke: A Meta-analysis of Cohort Studies', American Journal of Kidney Diseases, 53, pp. 417 - 425, http://dx.doi.org/10.1053/j.ajkd.2008.08.032

Patel A; Chalmers J; Macmahon S; Neal B, 2009, 'ADVANCE: Blood pressure lowering in diabetes', Journal of Clinical Hypertension, 11, pp. 108, http://dx.doi.org/10.1111/j.1751-7176.2008.00067_1.x

Patel A; Chalmers J; MacMahon S; Neal B, 2009, 'ADVANCE: Blood Pressure Lowering in Diabetes', JOURNAL OF CLINICAL HYPERTENSION, 11, pp. 108 - 108, http://dx.doi.org/10.1111/j.1751-7176.2008.00067_1.x

Tavakoli M; Pumford N; Woodward M; Doney A; Chalmers J; MacMahon S; MacWalter R, 2009, 'An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event', European Journal of Health Economics, 10, pp. 111 - 119, http://dx.doi.org/10.1007/s10198-008-0108-3

Ninomiya T; Perkovic V; De Galan BE; Zoungas S; Pillai A; Jardine M; Patel A; Cass A; Neal B; Poulter N; Mogensen CE; Cooper M; Marre M; Williams B; Hamet P; Mancia G; Woodward M; MacMahon S; Chalmers J, 2009, 'Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes', Journal of the American Society of Nephrology, 20, pp. 1813 - 1821, http://dx.doi.org/10.1681/ASN.2008121270

Zoungas S; Chalmers J; Patel A, 2009, 'Cardiovascular risk in type 2 diabetes - Reflecting on the ADVANCE study', US Endocrinology, 5, pp. 95 - 99, http://dx.doi.org/10.17925/use.2009.05.1.42

Back to profile page